The Latest Cardiac and Vascular News
SAN FRANCISCO & ORLANDO, Fla.–(BUSINESS WIRE)–Viz.ai – the world leader in AI-driven intelligent care coordination, today announced the U.S. commercial launch of its AI-powered modules for pulmonary embolism and aortic disease. Debuting at the 48th annual VEITHsymposium November 16 – 20 in Orlando, Fla., the new modules allow for faster clinical decision making and improved […]
Company partners with the leading academic institution on research and development of AI-driven methods for atrial fibrillation procedures Westport, CT, Nov. 16, 2021 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal processing platform designed to improve signal […]
VASCEPA/VAZKEPA found in prespecified and post hoc analyses to reduce total ischemic events by 32% in patients with prior PAD DUBLIN, Ireland and BRIDGEWATER, N.J., Nov. 16, 2021 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN) today reported an overview of new data relating to VASCEPA®/VAZKEPA (icosapent ethyl) presented at the […]
Two New Studies Presented at the American Heart Association Scientific Sessions 2021, Adoption of Technology Reported as “Excellent” and “Valuable” by Lead Authors Oak Ridge, TN, Nov. 16, 2021 (GLOBE NEWSWIRE) — Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, today announces new data validating the benefits of the […]
REDWOOD CITY, Calif., Nov. 15, 2021 (GLOBE NEWSWIRE) — HeartFlow, Inc., the leader in revolutionizing precision heart care, today announced the appointment of Wayne J. Riley, MD, to its Board of Directors. “We are very honored to have Dr. Riley join HeartFlow’s Board of Directors,” said William C. Weldon, Chairman of […]
— Patency and host cell remodeling of the HAV were observed in all study implants – — Preclinical study is one component of Humacyte’s expansion of the testing of the HAV in a broader cardiac bypass surgery application – DURHAM, N.C., Nov. 16, 2021 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a […]
Multinational study data highlighted at 2021 American Heart Association (AHA) Scientific Sessions November 16, 2021 09:00 AM Eastern Standard Time KIRKLAND, Wash.–(BUSINESS WIRE)–Prevencio, Inc. today announces the presentation of multinational patient data demonstrating its HART CADhs blood test is significantly more accurate than high sensitivity troponin in determining whether a diabetic patient has […]
Debuted as a public company and strengthened liquidity position with $95.1 million in gross proceeds from the business combination with Chardan Healthcare Acquisition 2 Corp and concurrent PIPE financing Released topline preclinical data demonstrating feasibility of REN-001 to transduce a large animal heart via local infusion at low vector doses […]
MORRISVILLE, N.C.–(BUSINESS WIRE)–Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need, today reported financial results for the third quarter of 2021 and provided a business update. “As we approach the new year, […]
Conference call begins at 4:30 p.m. Eastern time today November 15, 2021 04:05 PM Eastern Standard Time CARLSBAD, Calif.–(BUSINESS WIRE)–Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on developing its excimer laser system to treat vascular disease, reports financial results for the three and nine months […]
